Introducing our new Adviser Centre!

At Fundamental Asset, we understand the important role financial advisers play in helping clients make good financial decisions to achieve their goals. We feel it is our duty to support you in this which is why we have created our new Adviser Centre.

Our Adviser Centre is designed to make your life easier and has everything you need to manage and support your clients. This dedicated adviser area includes our educational webinar and literature libraries, client case studies and detailed insights. You can also build your own illustration, find details of your dedicated relationship manager and find links to all our third-party platform partners.

Here is a quick summary of some of the resources to help you as financial adviser:

Adviser Guides

We understand that AIM investing is one part of several areas where you support clients. Fundamental Asset are AIM specialists and we take it upon ourselves to support you by providing expert knowledge on everything you need to know about AIM. Our guides so far include Investing in AIM for Inheritance tax and how to discuss risk in AIM with clients. Keep an eye out for more specialist guides over the next few months.

Case Studies

Our library of case studies is designed to be short refresher guides covering various client scenarios where an AIM portfolio can help you and your clients. This may reinforce your understanding of where AIM can help your clients or it might help unlock an opportunity in your existing client base.

Build an Illustration

You can now build your own illustration on our website using our new illustration builder. This can include your adviser remuneration as well as our own management fees and any third-party platform fees. Give it a try!

Your Relationship Manager

We understand how important it is for you to have a direct line of communication with any investment manager managing money on behalf of your clients and we want to be as open and contactable to you as we can possibly be. As such, not only do you have a dedicated contact but you can even call directly into our cofounders and portfolio managers.

Educational Webinars

Every month we present an educational webinar on AIM to the adviser community. These include topics such as post-Covid opportunities in AIM, all you need to know about investing in AIM for IHT and even discussing risk in AIM with clients. All these sessions are available to watch on-demand through our online adviser centre. You can even register for any up-coming sessions here too!

Our Platform Partners

Platforms play an important part in most financial adviser business models by removing unnecessary risk, reducing time spent on administration and expanding investment options. We recognise this, and so we position our AIM Inheritance Tax ISA and AIM Inheritance Tax Portfolio service on many of the key adviser platforms in the UK. Have a look on our adviser centre to see if we are on your chosen platform.


We have even built a large database of frequently asked questions from advisers to help you get a quick answer to a common question.


Our Adviser Centre is designed to make life easier by helping you support and manage your client bank. Take a look! and let me know what you think.

Enjoy your weekend!

Derek Mclay

Business Development Manager

077437 25659/ [email protected]


Join me and the Fundamental Asset Team where we will be introducing our new Adviser Centre and discussing how AIM can help you and your clients.

Click the picture below to register for our session: How can AIM help you and your clients?

You can find out more about Fundamental Asset Management’s high performing AIM IHT ISA and AIM Inheritance Tax portfolio service, which has been delivering exceptional investment returns for more than 16 years, from the link here.


Sunak scraps the Budget – should AIM tax reliefs be enhanced?

The popular press had previously alluded to the potential withdrawal of Inheritance Tax/Business Relief on AIM shares. With Chancellor Sunak scrapping his autumn Budget, as he focuses on matters of more immediate concern to the economic welfare of the country, any adverse tax changes for holders of AIM shares therefore appear to be off the table for the time being.

As we have suggested before, the Chancellor may be more inclined to extend tax reliefs for those supporting smaller companies in an effort to unlock the considerable savings held by the wealthier members of the population, which are effectively being eroded due to inflation and the derisory interest available on savings accounts.

The poor returns generated by the main UK stock market over the last decade and the significant outperformance of AIM portfolios over this period also suggests that investors would have been far better off investing in smaller, faster growing companies on AIM, than many of the aged dinosaurs of the main market.

Numerous small AIM pharmaceutical and biotech groups have been at the forefront of developing tests and vaccines in the battle against Covid-19. This has not been possible without the support of their shareholders, many of whom have been encouraged to invest with the added attraction of various tax reliefs.

Specialist research house, Equity Development, previously highlighted the huge benefits AIM brings to the UK economy and how the mild encouragement provided by the Inheritance Tax concession to those considering an IPO onto AIM is a very large multiple of the cost in tax foregone by HMRC.

Equity Development considers AIM companies contributed over £33bn Gross Value Added (GVA) directly – over 40% more per employee than the national average – and just as much indirectly to the UK economy since their direct GVA has increased by 35% in the last five years, more than twice as fast as the average. Not only are AIM companies more productive than average, their productivity is growing – at 11% pa, significantly faster than average.

A report by Grant Thornton on AIM’s first 25 years shows that small companies listed on AIM perform ‘better’ – generating more added value, more employment and far greater tax receipts for HMRC – than comparable “private” companies.

AIM’s superior growth has, in just the last five years, added £4.7bn pa to UK economy and more than £1bn per annum to HMRC. Rishi, take note!

Many investors and advisers are fearful of the perceived extra risk of investing in AIM. Our forthcoming webinar ‘The Truth about Risk on AIM’ will cover this and other misconceptions about AIM.  You can register for the event by visiting the link here.

Not only is AIM of huge benefit to the UK economy but AIM listed companies represent the primary source of growth for UK small cap investors, reflected in the significant outperformance of AIM for IHT managers, including Fundamental, over the past decade or more.

Since launch on 19 June 1995, AIM has supported nearly four-thousand growth companies in raising over £117bn, 61% of which has been through follow-on fundraisings. The equity fund raisings over the pandemic have seen investors plough £billions into UK companies, removing a further burden from the government.  For the eight months to the end of August AIM companies have raised £3.6 billion of follow-on capital.

We reiterate our suggestions that, for a limited period, the UK government should actually consider enhancing the tax incentives for investing in the newly issued shares of UK listed companies, whatever their size, whether on the main market or AIM. Now that’s a radical thought!

Chris Boxall

Cofounder & Co-Director

Please join the Fundamental team at our webinar ‘The Truth about Risk in AIM’.

Click the picture below to register..

You can find out more about Fundamental Asset Management’s high performing AIM portfolio service, which has been delivering exceptional investment returns for more than 16 years, from the link here.


Common AIM Myths Debunked!

AIM is often considered a higher risk market due to the increased volatility, but does heightened volatility really amount to greater risk?

From our perspective the purest definition of risk is the likelihood of a permanent loss of capital and, over the last 10 years, AIM’s larger companies have been better at delivering capital growth to investors than their UK main market peers..

There are many misconceptions and myths surrounding AIM. Here’s the truth on some of these below..

Your Capital Risk is at risk in AIM.. This is true

Like other equity markets, AIM carries capital risk and AIM has had a few high profile failures, including Conviviality, Patisserie Valerie and Silverdell. However, these are rare cases and the quality of companies and AIM’s governance has improved considerably over recent years. Although it used to have a wild west reputation the reality is that AIM is now a much more stable market, worth just over £100bn.

AIM Shares are Illiquid.. myth

Many AIM shares are less liquid than the main large market stocks, however, many main market companies are also far less liquid than similar sized AIM stocks. The value of AIM shares traded in August 2020 was over £5 billion with AIM’s largest company seeing £587 million of shares traded. Unless you are a large retail investor (£100m+), an institutional investor, or forced to sell during market sell-offs, liquidity risk should not be an issue.

Concentration is an issue for AIM.. can be true

Concentration can be an issue for some large AIM investment managers as AIM is designed to be a market for smaller companies and those managing significant assets for clients will risk owning too much of a single company. However, for Fundamental Asset Management this is not a concern. We are large enough to take advantage of scale but small enough not to have any concentration worries.

AIM is unregulated? ..Fake News!

AIM was established as part of the London Stock Exchange in 1995 and is a regulated market, although not to the same extent as the main market. There are firm corporate governance rules in place, and a variety of procedures and checks for constituent companies to follow. AIM is subject to the UK Market Abuse Regime and the majority of companies are subject to the rules of the UK Takeover Panel and the Companies Act.

AIM has only young and high-risk companies? Fake News!

AIM was designed for younger companies but has been around for 25 years. Many of those early business grew over time and the average market capitalisation is now around £130m. In fact, 20 companies have a market cap of over £1bn and the overall market value was £107bn at the end of August. The wide range of companies across numerous sectors means that investors can pursue different investment strategies within AIM.

Tax is the only reason to invest in AIM? Fake News!

AIM is one of the most successful growth markets in the world. AIM stocks pay no stamp duty, can be held in an ISA and many AIM companies also qualify for relief from Inheritance Tax through the Business Relief.  The Numis Alternative Markets Index has returned 16.2% over the five years to 30 April 2020 (FTSE100 Index declined -4.9%), and dividends paid by AIM companies burst through the £1 billion mark for the first time in 2018. This makes for a much more enticing investment opportunity far beyond tax driven incentives.

Join me and the Fundamental Asset Team where we will be discussing more truths about risk in AIM.

Click the picture below to register for our session: The Truth about Risk in AIM

You can find out more about Fundamental Asset Management’s high performing AIM portfolio service, which has been delivering exceptional investment returns for more than 16 years, from the link here.


What is driving AIM’s outperformance?

The AIM index is up 30% since 1st April i.e. Q2 2020. Maybe this is not surprising when you consider that it fell by 29% in Q1 and, as has been widely reported in the mainstream press, markets have rebounded.

However, when you compare to the UK main markets, AIM has massively outperformed in Q2 with the FTSE 100 and FTSE All-Share up c10% and 11% respectively. And, it’s not if the main markets didn’t fall as much in the first quarter. The 100 was down 25% and the All-Share 26%.

So what is driving AIM?

Well, it is probably a number of factors.

Firstly, it has been well documented for some time that the FTSE 100 is full of pretty dull and uninspiring companies and that can partly explain why it has also underperformed the S&P500. The UK blue-chips did benefit last year from a weakening pound as overseas investors bought cheaper assets and yield. With Sterling still relatively weak, it appears that no longer remains an attraction.

However, that aside it is more likely that the dominance of a few underlying companies is distorting the index and this has always been the problem of using AIM as a comparative index.

There were 831 companies listed on AIM at the end of May 2020, with the combined market capitalisation of the market c£95.3bn. There were 17 companies individually valued at more than £1bn, which between them represented 34% of the total market capitalisation.

With AIM being a weighted index, i.e. the return of the index is based on a weighted return by market capitalisation, rather than each company being weighted equally as the US Dow Jones is for example, it is fair to say that those 18 companies will really move the needle.

And if we look into some of those companies, you will see the influence they have.

Probably two of the most well known companies listed on AIM are online clothing retailers Boohoo and ASOS. Boohoo, with a market cap of c£5bn is comfortably the largest company on AIM by value, being £1.5bn more than the next on the list, Abcam.

Combined, these companies represent over 8% of the index. When you consider that ASOS is up 177% in this quarter alone and Boohoo 115%, returning to pre -lockdown levels, you can see the influence they are having on the index as a whole. ITM Power, another £1bn+ company is also up over 100% quarter to date.

Unless you are holding these companies in your portfolio, it is very likely that your AIM portfolio is going to be significantly underperforming the AIM index.

So although the AIM index has been a better indicator for AIM portfolios in recent years, it goes to show that it can be misleading in extraordinary times.

You can find out more about Fundamental’s high performing AIM portfolio service, including the latest fact sheet for May, from the link here.


RWS Holdings (AIM:RWS) – whopping acquisition significantly earnings enhancing

The world’s leading provider of patent translations, international patent filing solutions and searches has announced a significant acquisition that is expected to be immediately and significantly earnings enhancing.

 The AIM quoted Group has acquired Corporate Translations Inc (“CTi”) for a cash consideration of US$70 million. Based in Connecticut, USA, with 140 employees, CTi is the world’s leading life sciences translation and linguistic validation provider. The Company was founded in 1990 specifically to cater for the growing demand for high quality translation services in the life sciences sector and is now a recognised leader in successfully managing complex translation projects on behalf of the world’s top pharmaceutical and biotech companies and their Clinical Research Organisation (CRO) partners. It enjoys a preferred supplier relationship with many of its key customers, with extraordinary penetration of the blue chip life science community.

As CTi’s customers operate in highly regulated and audited industries, they place a premium on high quality translations being delivered to specific deadlines, which in turn underpins CTi’s attractive margins. RWS already focuses on the life sciences sector both through its patent translation and filing solutions and with its separate Medical Translation Division which includes the linguistic validation specialist PharmaQuest, a company acquired in 2013. The greater scale of CTi, combined with the existing specialist RWS divisions will immediately transform the Group to a world leading position in life sciences translations and linguistic validation and further enhance its competitive standing amongst the largest specialist translation companies in the world, especially in IP support services.

The acquisition of CTi is expected to be immediately and significantly earnings enhancing, with the US$70m consideration to be paid based on CTi reporting an EBITDA of not less than US$7m for the year ended 31 December 2015. CTI’s latest audited financial statements, for the year ended 31 December 2014, showed revenues of $23m and adjusted EBITDA of $4.8m.

The acquisition will be funded by $25m from internal cash resources (RWS had net cash of £30m at 30th Sept 2015) and US$45m through a five year loan provided by Barclays. The co-founders of CTi, will retain their current positions for up to a year, to allow the enlarged Group to benefit from their significant knowledge and experience as they integrate the business into the enlarged Group.

They are certainly paying what looks like a hefty price for CTI but many have been concerned how the Group’s growing cash pile could be best utilised and this acquisition appears to deliver on many fronts.

Forecasts for the year ending September 2016 were previously for pre-tax profit of £22.1m and eps of 8.0p. One senses a minimum 10% earnings upgrade is probably anticipated following the acquisition moving the earnings number closer to 9p.

UPDATE – Broker forecasts

The house broker has actually raised their EPS forecasts by 20%.
Financial Year moves to 9.6p from 8.0p, with 2017 raised to 10.1p from 8.4p.

– See more at: